General Information of the Compound
| Compound ID |
CP0389791
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[[(1R,2R,3aS,7aS)-2-[(3R)-3-aminopiperidin-1-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-1-yl]oxy]benzonitrile
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H31N3O
|
||||||||||||||||||
| Molecular Weight |
353.51
|
||||||||||||||||||
| Canonical SMILES |
C[C@]12CCCC[C@H]1C[C@H]([C@@H]2Oc1ccc(cc1)C#N)N1CCC[C@@H](N)C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H31N3O/c1-22-11-3-2-5-17(22)13-20(25-12-4-6-18(24)15-25)21(22)26-19-9-7-16(14-23)8-10-19/h7-10,17-18,20-21H,2-6,11-13,15,24H2,1H3/t17-,18+,20+,21-,22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BMHNWVVGDYARHP-XWZZJKMASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT04958, Short transient receptor potential channel 6
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha